Prenatal	prenatal	O	O
exposure	exposure	O	O
to	to	O	O
fluoxetine	fluoxetine	S_chemical	O
induces	induces	O	O
fetal	fetal	O	O
pulmonary	pulmonary	O	B_disease
hypertension	hypertension	O	S_disease
in	in	O	O
the	the	O	O
rat	rat	O	O
.	.	O	O

RATIONALE	rationale	O	O
:	:	O	O
Fluoxetine	fluoxetine	S_chemical	O
is	is	O	O
a	a	O	O
selective	selective	O	O
serotonin	serotonin	S_chemical	O
reuptake	reuptake	O	O
inhibitor	inhibitor	O	O
antidepressant	antidepressant	S_chemical	O
widely	widely	O	O
used	used	O	O
by	by	O	O
pregnant	pregnant	O	O
women	women	O	O
.	.	O	O

Epidemiological	epidemiological	O	O
data	data	O	O
suggest	suggest	O	O
that	that	O	O
fluoxetine	fluoxetine	S_chemical	O
exposure	exposure	O	O
prenatally	prenatally	O	O
increases	increases	O	O
the	the	O	O
prevalence	prevalence	O	O
of	of	O	O
persistent	persistent	O	O
pulmonary	pulmonary	O	B_disease
hypertension	hypertension	O	S_disease
syndrome	syndrome	O	O
of	of	O	O
the	the	O	O
newborn	newborn	O	O
.	.	O	O

The	the	O	O
mechanism	mechanism	O	O
responsible	responsible	O	O
for	for	O	O
this	this	O	O
effect	effect	O	O
is	is	O	O
unclear	unclear	O	O
and	and	O	O
paradoxical	paradoxical	O	O
,	,	O	O
considering	considering	O	O
the	the	O	O
current	current	O	O
evidence	evidence	O	O
of	of	O	O
a	a	O	O
pulmonary	pulmonary	O	B_disease
hypertension	hypertension	O	S_disease
protective	protective	O	O
fluoxetine	fluoxetine	S_chemical	O
effect	effect	O	O
in	in	O	O
adult	adult	O	O
rodents	rodents	O	O
.	.	O	O

OBJECTIVES	objectives	O	O
:	:	O	O
To	to	O	O
evaluate	evaluate	O	O
the	the	O	O
fluoxetine	fluoxetine	S_chemical	O
effect	effect	O	O
on	on	O	O
fetal	fetal	O	O
rat	rat	O	O
pulmonary	pulmonary	O	O
vascular	vascular	O	O
smooth	smooth	O	O
muscle	muscle	O	O
mechanical	mechanical	O	O
properties	properties	O	O
and	and	O	O
cell	cell	O	O
proliferation	proliferation	O	O
rate	rate	O	O
.	.	O	O

METHODS	methods	O	O
:	:	O	O
Pregnant	pregnant	O	O
rats	rats	O	O
were	were	O	O
treated	treated	O	O
with	with	O	O
fluoxetine	fluoxetine	S_chemical	O
(	(	O	O
10	10	O	O
mg/kg	mg/kg	O	O
)	)	O	O
from	from	O	O
Day	day	O	O
11	11	O	O
through	through	O	O
Day	day	O	O
21	21	O	O
of	of	O	O
gestation	gestation	O	O
.	.	O	O

MEASUREMENTS	measurements	O	O
AND	and	O	O
MAIN	main	O	O
RESULTS	results	O	O
:	:	O	O
Fetuses	fetuses	O	O
were	were	O	O
delivered	delivered	O	O
by	by	O	O
cesarean	cesarean	O	O
section	section	O	O
.	.	O	O

As	as	O	O
compared	compared	O	O
with	with	O	O
controls	controls	O	O
,	,	O	O
fluoxetine	fluoxetine	S_chemical	O
exposure	exposure	O	O
resulted	resulted	O	O
in	in	O	O
fetal	fetal	O	O
pulmonary	pulmonary	O	B_disease
hypertension	hypertension	O	S_disease
as	as	O	O
evidenced	evidenced	O	O
by	by	O	O
an	an	O	O
increase	increase	O	O
in	in	O	O
the	the	O	O
weight	weight	O	O
ratio	ratio	O	O
of	of	O	O
the	the	O	O
right	right	O	O
ventricle	ventricle	O	O
to	to	O	O
the	the	O	O
left	left	O	O
ventricle	ventricle	O	O
plus	plus	O	O
septum	septum	O	O
(	(	O	O
P	p	O	O
=	=	O	O
0.02	0.02	O	O
)	)	O	O
and	and	O	O
by	by	O	O
an	an	O	O
increase	increase	O	O
in	in	O	O
pulmonary	pulmonary	O	O
arterial	arterial	O	O
medial	medial	O	O
thickness	thickness	O	O
(	(	O	O
P	p	O	O
<	<	O	O
0.01	0.01	O	O
)	)	O	O
.	.	O	O

Postnatal	postnatal	O	O
mortality	mortality	O	O
was	was	O	O
increased	increased	O	O
among	among	O	O
experimental	experimental	O	O
animals	animals	O	O
,	,	O	O
and	and	O	O
arterial	arterial	O	O
oxygen	oxygen	S_chemical	O
saturation	saturation	O	O
was	was	O	O
96	96	O	O
+	+	O	O
/-	/-	O	O
1	1	O	O
%	%	O	O
in	in	O	O
1-day-old	1-day-old	O	O
control	control	O	O
animals	animals	O	O
and	and	O	O
significantly	significantly	O	O
lower	lower	O	O
(	(	O	O
P	p	O	O
<	<	O	O
0.01	0.01	O	O
)	)	O	O
in	in	O	O
fluoxetine-exposed	fluoxetine-exposed	O	O
pups	pups	O	O
(	(	O	O
79	79	O	O
+	+	O	O
/-	/-	O	O
2	2	O	O
%	%	O	O
)	)	O	O
.	.	O	O

In	in	O	O
vitro	vitro	O	O
,	,	O	O
fluoxetine	fluoxetine	S_chemical	O
induced	induced	O	O
pulmonary	pulmonary	O	O
arterial	arterial	O	O
muscle	muscle	O	O
contraction	contraction	O	O
in	in	O	O
fetal	fetal	O	O
,	,	O	O
but	but	O	O
not	not	O	O
adult	adult	O	O
,	,	O	O
animals	animals	O	O
(	(	O	O
P	p	O	O
<	<	O	O
0.01	0.01	O	O
)	)	O	O
and	and	O	O
reduced	reduced	O	O
serotonin-induced	serotonin-induced	O	O
contraction	contraction	O	O
at	at	O	O
both	both	O	O
ages	ages	O	O
(	(	O	O
P	p	O	O
<	<	O	O
0.01	0.01	O	O
)	)	O	O
.	.	O	O

After	after	O	O
in	in	O	O
utero	utero	O	O
exposure	exposure	O	O
to	to	O	O
a	a	O	O
low	low	O	O
fluoxetine	fluoxetine	S_chemical	O
concentration	concentration	O	O
the	the	O	O
pulmonary	pulmonary	O	O
arterial	arterial	O	O
smooth	smooth	O	O
muscle	muscle	O	O
cell	cell	O	O
proliferation	proliferation	O	O
rate	rate	O	O
was	was	O	O
significantly	significantly	O	O
increased	increased	O	O
in	in	O	O
fetal	fetal	O	O
,	,	O	O
but	but	O	O
not	not	O	O
adult	adult	O	O
,	,	O	O
cells	cells	O	O
(	(	O	O
P	p	O	O
<	<	O	O
0.01	0.01	O	O
)	)	O	O
.	.	O	O

CONCLUSIONS	conclusions	O	O
:	:	O	O
In	in	O	O
contrast	contrast	O	O
to	to	O	O
the	the	O	O
adult	adult	O	O
,	,	O	O
fluoxetine	fluoxetine	S_chemical	O
exposure	exposure	O	O
in	in	O	O
utero	utero	O	O
induces	induces	O	O
pulmonary	pulmonary	O	B_disease
hypertension	hypertension	O	S_disease
in	in	O	O
the	the	O	O
fetal	fetal	O	O
rat	rat	O	O
as	as	O	O
a	a	O	O
result	result	O	O
of	of	O	O
a	a	O	O
developmentally	developmentally	O	O
regulated	regulated	O	O
increase	increase	O	O
in	in	O	O
pulmonary	pulmonary	O	O
vascular	vascular	O	O
smooth	smooth	O	O
muscle	muscle	O	O
proliferation	proliferation	O	O
.	.	O	O

